See more : Champion Technology Holdings Limited (0092.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Biogena Group Invest Ag (BIO.VI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Biogena Group Invest Ag, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
You may be interested
- Permanent TSB Group Holdings plc (PTSB.IR) Income Statement Analysis – Financial Results
- Desarrolladora Homex, S.A.B. de C.V. (DHHXF) Income Statement Analysis – Financial Results
- Stenocare A/S (STENO.CO) Income Statement Analysis – Financial Results
- Nac Co., Ltd. (9788.T) Income Statement Analysis – Financial Results
- Themis Medicare Limited (THEMISMED.NS) Income Statement Analysis – Financial Results
Biogena Group Invest Ag (BIO.VI)
About Biogena Group Invest Ag
Biogena Group Invest AG engages in the provision of dietary supplements. The company is based in Salzburg, Austria.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 166.06K | 251.06K | 331.06K | 329.30K |
| Cost of Revenue | 900.00 | 720.00 | 820.00 | 0.00 |
| Gross Profit | 165.16K | 250.34K | 330.24K | 329.30K |
| Gross Profit Ratio | 99.46% | 99.71% | 99.75% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 33.86K | 26.91K | 230.21K | 119.49K |
| Selling & Marketing | 2.91K | 5.72K | 17.68K | 5.26K |
| SG&A | 36.78K | 32.63K | 247.89K | 124.75K |
| Other Expenses | 124.95K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 161.72K | 156.54K | 404.96K | 288.46K |
| Cost & Expenses | 162.62K | 157.26K | 405.78K | 288.46K |
| Interest Income | 0.00 | 0.08 | 4.91 | 17.54 |
| Interest Expense | 180.38 | 1.22 | 2.63 | 0.00 |
| Depreciation & Amortization | 172.65K | 208.56K | 892.54K | 111.05K |
| EBITDA | 176.08K | 301.72K | 816.69K | 150.95K |
| EBITDA Ratio | 106.04% | 120.18% | 246.69% | 45.84% |
| Operating Income | 3.43K | 93.16K | -75.85K | 39.90K |
| Operating Income Ratio | 2.07% | 37.11% | -22.91% | 12.12% |
| Total Other Income/Expenses | 172.47K | 208.56K | 892.54K | 111.05K |
| Income Before Tax | 175.90K | 301.71K | 816.69K | 150.95K |
| Income Before Tax Ratio | 105.93% | 120.18% | 246.69% | 45.84% |
| Income Tax Expense | 3.50K | 3.52K | 81.43K | 34.29K |
| Net Income | 172.40K | 298.19K | 735.26K | 116.65K |
| Net Income Ratio | 103.82% | 118.77% | 222.09% | 35.42% |
| EPS | 0.00 | 0.07 | 0.18 | 0.06 |
| EPS Diluted | 0.00 | 0.07 | 0.18 | 0.06 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 3.99M | 1.99M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 3.99M | 1.99M |
No news found for: BIO.VI
Source: https://incomestatements.info
Category: Stock Reports